Literature DB >> 8789035

Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.

A Weinberg1, A R Hayward, H B Masters, I A Ogu, M J Levin.   

Abstract

We evaluated an enzyme-linked immunoassay (EIA; BioWhittaker) and a latex agglutination (LA; Becton Dickinson) for varicella-zoster virus (VZV) antibody determination, using cell-mediated immunity (CMI) as a "gold standard." VZV EIA had a sensitivity, specificity, positive predictive value, and negative predictive value of 87, 91, 87, and 91%, respectively, compared with CMI. Correlation was excellent except when the varicella index was 0.9 to 1.2. We defined sera with varicella indices of 0.9 to 1.2 as indeterminate. LA had a sensitivity, specificity, positive predictive value, and negative predictive value of 96, 91, 97, and 90%, respectively, compared with EIA. LA reactivity only at a 1:2 dilution did not correlate with CMI, but sera reactive at dilutions of > or = 1:8 indirectly did. We defined indeterminate sera as those reactive at 1:2 and nonreactive at 1:8. EIA and LA were equivalent for determining VZV immune status, and both methods required modified criteria of interpretation to increase their specificity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789035      PMCID: PMC228817          DOI: 10.1128/jcm.34.2.445-446.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.

Authors:  R H Giller; S Winistorfer; C Grose
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

2.  Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Authors:  S P Steinberg; A A Gershon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

3.  Comparison of five assays for antibody to varicella-zoster virus and the fluorescent-antibody-to-membrane-antigen test.

Authors:  P Larussa; S Steinberg; E Waithe; B Hanna; R Holzman
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

4.  Varicella vaccine studies in healthy children and adults.

Authors:  A M Arbeter; S E Starr; S A Plotkin
Journal:  Pediatrics       Date:  1986-10       Impact factor: 7.124

5.  Acyclovir prophylaxis of varicella after household exposure.

Authors:  Y C Huang; T Y Lin; C H Chiu
Journal:  Pediatr Infect Dis J       Date:  1995-02       Impact factor: 2.129

6.  Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection.

Authors:  A M Arvin; C M Koropchak; B R Williams; F C Grumet; S K Foung
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

7.  Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity.

Authors:  B Watson; P M Keller; R W Ellis; S E Starr
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

8.  Immune responses to varicella zoster virus infections in healthy children.

Authors:  H A Rotbart; M J Levin; A R Hayward
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

9.  Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life.

Authors:  A A Gershon; R Raker; S Steinberg; B Topf-Olstein; L M Drusin
Journal:  Pediatrics       Date:  1976-11       Impact factor: 7.124

10.  Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.

Authors:  J A Zaia; M J Levin; S R Preblud; J Leszczynski; G G Wright; R J Ellis; A C Curtis; M A Valerio; J LeGore
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

View more
  4 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

2.  Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 3.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

4.  Study of susceptibility towards varicella by screening for the presence of IgG antibodies among nursing and medical students of a tertiary care teaching hospital in pune, India.

Authors:  Samir A Singru; Vijay W Tilak; N Gandham; Jitendra S Bhawalkar; Sudhir L Jadhav; Harshal T Pandve
Journal:  J Glob Infect Dis       Date:  2011-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.